Holen Sie sich die Stockscreener-App
177.74
0.22%
-0.40
Handel nachbörslich:
177.74
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$178.14
Offen:
$178.19
24-Stunden-Volumen:
911.44K
Relative Volume:
0.87
Marktkapitalisierung:
$19.77B
Einnahmen:
$10.52B
Nettoeinkommen (Verlust:
$999.00M
KGV:
21.25
EPS:
8.3628
Netto-Cashflow:
$1.22B
1W Leistung:
+2.43%
1M Leistung:
-2.24%
6M Leistung:
+3.04%
1J Leistung:
+15.39%
1-Tages-Spanne:
$176.70
$180.66
1-Wochen-Bereich:
$171.18
$181.23
52-Wochen-Spanne:
$148.70
$197.55
Quest Diagnostics Inc Stock (DGX) Company Profile
Firmenname
Quest Diagnostics Inc
Sektor
Branche
Telefon
(973) 520-2700
Adresse
500 PLAZA DRIVE, SECAUCUS
Vergleichen Sie DGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
177.74 | 19.82B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
606.50 | 231.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.00 | 166.39B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
712.39 | 57.06B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
243.19 | 41.60B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
145.76 | 41.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-01-06 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | Fortgesetzt | Evercore ISI | In-line |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-06-29 | Eingeleitet | Piper Sandler | Neutral |
| 2023-05-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-01-23 | Eingeleitet | Evercore ISI | In-line |
| 2022-11-17 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-02-23 | Herabstufung | UBS | Buy → Neutral |
| 2022-02-02 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-04 | Hochstufung | UBS | Neutral → Buy |
| 2021-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | Hochstufung | Argus | Hold → Buy |
| 2020-07-29 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-06-09 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-04-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-12-19 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | Herabstufung | Goldman | Neutral → Sell |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-03-18 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-01-31 | Herabstufung | Argus | Buy → Hold |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | Herabstufung | Goldman | Buy → Neutral |
Alle ansehen
Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026 - Finviz
Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs - PharmiWeb.com
New 30-minute at-home test helps women detect STIs privately - Stock Titan
$43.36 Bn Autism Spectrum Disorder Diagnostics Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F - GlobeNewswire Inc.
Is It Time To Reassess Quest Diagnostics (DGX) After Recent Share Price Strength? - Yahoo Finance
Data Featuring Haystack MRD from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium - Finviz
Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium – Company AnnouncementFT.com - Financial Times
Corewell Health, Quest Diagnostics form joint venture - Modern Healthcare News
Quest Diagnostics, Corewell Health Complete Laboratory JV in Michigan - MarketScreener
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan - Finviz
What You Need To Know Ahead of Quest Diagnostics' Earnings Release - inkl
Quest Diagnostics Incorporated $DGX Shares Sold by SteelPeak Wealth LLC - MarketBeat
Quest Diagnostics Find A Testfav Events Billing & Coding- - shababeek.org
RSI Alert: Quest Diagnostics Now Oversold - Nasdaq
Quest Diagnostics Incorporated $DGX Shares Purchased by Braun Stacey Associates Inc. - MarketBeat
Ethic Inc. Increases Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks - Finviz
Boston Trust Walden Corp Sells 53,026 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics (DGX) Upgraded to Buy: Here's Why - Yahoo Finance
Copeland Capital Management LLC Sells 7,889 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Harbor Capital Advisors Inc. Has $596,000 Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Pacer Advisors Inc. Grows Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Assenagon Asset Management S.A. Lowers Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? - sharewise.com
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Quest Diagnostics Incorporated $DGX Shares Sold by Coho Partners Ltd. - MarketBeat
Voya Investment Management LLC Reduces Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Thrivent Financial for Lutherans Purchases 11,351 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Corient Private Wealth LLC Has $4.49 Million Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
What is the fair value of Quest Diagnostics Incorporated stock now2025 Bull vs Bear & Expert Curated Trade Setups - Улправда
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference - PR Newswire
Quest Diagnostics Incorporated's (NYSE:DGX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Quest Diagnostics Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
What market sentiment indicators show for Quest Diagnostics Incorporated (QDI) stockStock Surge & Proven Capital Preservation Tips - DonanımHaber
Is Quest Diagnostics Incorporated stock a buy during volatile markets2025 Winners & Losers & Weekly Stock Performance Updates - DonanımHaber
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Is Quest Diagnostics Incorporated stock a safe haven asset2025 Volume Leaders & High Yield Equity Trading Tips - Улправда
How Quest Diagnostics Incorporated stock trades after rate cutsJuly 2025 Momentum & Free Technical Pattern Based Buy Signals - Улправда
Aaron Wealth Advisors LLC Makes New Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Quest Diagnostics stock: Is DGX outperforming the healthcare sector? - MSN
Quest Diagnostics (NYSE:DGX) Shares Unloaded Rep. Julie Johnson - MarketBeat
Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector? - Barchart.com
Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Bellevue Group AG Makes New $8.72 Million Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock - Yahoo Finance
Bayesian Capital Management LP Takes Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Looking Into Quest Diagnostics Inc's Recent Short Interest - Sahm
California Public Employees Retirement System Reduces Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Finanzdaten der Quest Diagnostics Inc-Aktie (DGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
2.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):